Robyn Lynne Mah, PHARMD
Pharmacist · Santa Clara
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
- 1 Medical Board action on record
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Robyn Lynne Mah’s office at (408) 871-6350 to ask if they take your plan before you enroll.
California Medical Board record
Licence C53967 · Current
Licensed to practise in California · since 2010 · expires 2027-06-30 · University of the Punjab, Rawalpindi Medical College.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 2013-06-24 | Board disciplineDiscipline | Surrender of license. · 08 2010211019 |
Drugs they prescribed that Part D paid
$2,058
Pharmacies billed $2,058 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 106) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
106 generic and 0 brand-name prescriptions · $2,058 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levothyroxine | 45 | $1,781 | $18 |
Year by year
| 2024 | 106 | 46 | 0% (0) | 0% | $2,058 |
| 2023 | 210 | 71 | 0% (0) | 0% | $5,022 |
| 2022 | 296 | 102 | 0% (0) | None | $7,614 |
| 2021 | 308 | 112 | 0% (0) | None | $14,947 |
| 2020 | 284 | 110 | 0% (0) | None | $12,120 |
| 2019 | 249 | 92 | 0% (0) | None | $8,903 |
| 2018 | 347 | 141 | 0% (0) | 13% | $19,205 |
| 2017 | 735 | 206 | 0% (0) | 27% | $57,234 |
| 2016 | 614 | 192 | 0% (0) | 25% | $58,424 |
| 2015 | 590 | 214 | 0% (0) | 28% | $42,756 |
| 2014 | 489 | 183 | 0% (0) | 22% | $30,249 |
| 2013 | 431 | 155 | 0% (0) | 27% | $30,631 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Levothyroxine | 195 | $4,023 | $21 |
2022: 1 drug
| Levothyroxine | 286 | $6,388 | $22 |
2021: 1 drug
| Levothyroxine | 283 | $6,400 | $23 |
2020: 1 drug
| Levothyroxine | 255 | $6,875 | $27 |
2019: 1 drug
| Levothyroxine | 232 | $6,490 | $28 |
2018: 3 drugs
| Levothyroxine | 216 | $6,163 | $29 |
| Atorvastatin | 29 | $779 | $27 |
| Metformin | 17 | $252 | $15 |
2017: 14 drugs
| Lantus | 14 | $10,993 | $785 |
| Levothyroxine | 245 | $7,226 | $29 |
| Humulin N | 28 | $4,233 | $151 |
| Humalog | 17 | $3,913 | $230 |
| Atorvastatin | 120 | $3,333 | $28 |
| Glipizide | 52 | $849 | $16 |
| Insulin | 26 | $579 | $22 |
| Metformin | 40 | $563 | $14 |
| Simvastatin | 14 | $443 | $32 |
| Lisinopril | 24 | $407 | $17 |
| Alendronate | 26 | $369 | $14 |
| Losartan | 12 | $294 | $24 |
| Metformin Hcl Er | 23 | $282 | $12 |
| Hydrochlorothiazide | 11 | $102 | $9 |
2016: 11 drugs
| Lantus | 12 | $9,686 | $807 |
| Levothyroxine | 210 | $7,267 | $35 |
| Humulin N | 34 | $4,651 | $137 |
| Atorvastatin | 68 | $2,298 | $34 |
| Glipizide | 53 | $894 | $17 |
| Insulin | 32 | $633 | $20 |
| Metformin | 24 | $353 | $15 |
| Alendronate | 20 | $299 | $15 |
| Lisinopril | 24 | $293 | $12 |
| Simvastatin | 15 | $282 | $19 |
| Atenolol | 11 | $135 | $12 |
2015: 10 drugs
| Lantus | 14 | $15,688 | $1,121 |
| Levothyroxine | 209 | $7,116 | $34 |
| Humulin N | 43 | $4,862 | $113 |
| Atorvastatin | 89 | $2,861 | $32 |
| Insulin | 40 | $1,754 | $44 |
| Glipizide | 41 | $612 | $15 |
| Simvastatin | 18 | $341 | $19 |
| Metformin | 20 | $280 | $14 |
| Alendronate | 17 | $253 | $15 |
| Metformin Hcl Er | 15 | $175 | $12 |
2014: 9 drugs
| Lantus | 13 | $8,342 | $642 |
| Levothyroxine | 201 | $5,008 | $25 |
| Humulin N | 24 | $2,695 | $112 |
| Atorvastatin | 39 | $1,335 | $34 |
| Insulin | 28 | $1,150 | $41 |
| Glipizide | 28 | $342 | $12 |
| Metformin | 20 | $258 | $13 |
| Alendronate | 17 | $253 | $15 |
| Lisinopril | 11 | $125 | $11 |
2013: 10 drugs
| Levothyroxine | 157 | $4,154 | $26 |
| Humulin N | 35 | $3,211 | $92 |
| Humulin R | 14 | $1,143 | $82 |
| Atorvastatin | 26 | $934 | $36 |
| Insulin | 20 | $695 | $35 |
| Allopurinol | 11 | $396 | $36 |
| Glipizide | 24 | $383 | $16 |
| Amlodipine Besylate | 14 | $299 | $21 |
| Metformin Hcl Er | 14 | $188 | $13 |
| Alendronate | 12 | $172 | $14 |
Professional record
- NPI
- 1568554798
- Licence
- CA 53967California C53967: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 710 Lawrence Expy, 3rd Floor M3453, Santa Clara, CA, 95051
- NPI first listed
- 2006-09-28
- NPI last updated
- 2021-12-21
- NPI record certified
- 2021-12-21
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.